Zobrazeno 1 - 10
of 497
pro vyhledávání: '"WH West"'
Autor:
Lin, Xuefei1 (AUTHOR), Chang, Xiao1 (AUTHOR), Zhang, Yizheng2,3,4 (AUTHOR), Gao, Zhanyu2,3,4,5 (AUTHOR), Chi, Xu2,3 (AUTHOR) chix@big.ac.cn
Publikováno v:
NPJ Systems Biology & Applications. 11/9/2024, Vol. 10 Issue 1, p1-10. 10p.
Publikováno v:
Bone Marrow Transplantation. 21:383-389
Forty-nine patients with low-grade non-Hodgkin's lymphoma (NHL) received high-dose chemotherapy (HDC) with busulfan and cyclophosphamide (BUCY) or carmustine, etoposide, cytarabine and CY (BEAC) followed by unpurged autologous peripheral blood stem (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3fd8a662f9c7bfd3c0edb841087303
https://doi.org/10.1038/sj.bmt.1701101
https://doi.org/10.1038/sj.bmt.1701101
Autor:
C H Weaver, Tauer Kw, M Mangum, Lee S. Schwartzberg, P Kaywin, R Leff, FA Greco, K Pendergrass, Buckner Cd, WH West, J Hainsworth, A Rosenberg, B Zhen
Publikováno v:
Bone Marrow Transplantation. 20:753-760
The outcomes for patients with non-Hodgkin's lymphoma (NHL) treated with high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) infusion by practicing oncologists in community cancer centers in the United States were determined. Eighty-th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910d80d20d31a0939e9e85e5bf1ccc79
https://doi.org/10.1038/sj.bmt.1700975
https://doi.org/10.1038/sj.bmt.1700975
Autor:
Raefsky E, Kalman L, R Leff, WH West, FA Greco, B McAneny, Buckner Cd, C H Weaver, M Magee, J Hainsworth, T. Alberico, Lee S. Schwartzberg, R Birch
Publikováno v:
Bone Marrow Transplantation. 19:661-670
Summary: complete remission (CR) rates (40‐50%) with median overall survivals of 18‐24 months and progression-free survivals (PFS) of 12‐25% in patients with breast cancer We investigated the outcomes of patients with breast cancer undergoing i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0913572075e88adf15a955e52c4398b
https://doi.org/10.1038/sj.bmt.1700728
https://doi.org/10.1038/sj.bmt.1700728
Autor:
Amaral, A. C.1 (AUTHOR), Lister, J. P.1,2 (AUTHOR), Rueckemann, J. W.3 (AUTHOR), Wojnarowicz, M. W.1 (AUTHOR), McGaughy, J. A.4 (AUTHOR), Mokler, D. J.5 (AUTHOR), Galler, J. R.6,7 (AUTHOR), Rosene, D. L.1 (AUTHOR), Rushmore, R. J.1,8,9 (AUTHOR) rushmore@bu.edu
Publikováno v:
Nutritional Neuroscience. Aug2024, p1-14. 14p. 5 Illustrations.
Autor:
Tauer Kw, B McAneny, Buckner Cd, L Lewkow, B Zhen, Lee S. Schwartzberg, C H Weaver, WH West, R Birch
Publikováno v:
Bone marrow transplantation. 24(9)
The purpose of this study was to determine outcomes for 56 patients with inflammatory breast cancer (IBC) receiving high-dose chemotherapy (HDC) with cyclophosphamide, thiotepa and carboplatin (CTCb) with peripheral blood stem cell (PBSC) support. Al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd31fb1265b9a9413882361b327aec2b
https://pubmed.ncbi.nlm.nih.gov/10556957
https://pubmed.ncbi.nlm.nih.gov/10556957
Autor:
Carter P, Rymer W, Blanco R, F Wittlin, WH West, Lee S. Schwartzberg, Buckner Cd, R Leff, Campos L, F A Greco, Robert Birch, John D. Hainsworth, C H Weaver, M Mangum, Tauer Kw, Raefsky E
Publikováno v:
American journal of clinical oncology. 21(5)
The authors determined outcomes for patients with localized high-risk breast cancer undergoing sequential outpatient treatment with conventional-dose adjuvant therapy, chemotherapy, and growth factor mobilization of peripheral blood stem cells (PBSC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1810af907688cad6b50925d1e2a49f
https://pubmed.ncbi.nlm.nih.gov/9781614
https://pubmed.ncbi.nlm.nih.gov/9781614
Autor:
WH West, M Lewis, P Baldwin, C H Weaver, F Wittlin, B Zhen, Lee S. Schwartzberg, J Hainsworth, Buckner Cd, FA Greco
Publikováno v:
Bone marrow transplantation. 20(10)
The purpose of this study was to develop a high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) regimen for treatment of patients with ovarian carcinoma that could be administered in an outpatient setting. Fourteen patients with advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d730ace24f61c8cf05fa05e46c45db
https://pubmed.ncbi.nlm.nih.gov/9404925
https://pubmed.ncbi.nlm.nih.gov/9404925
Publikováno v:
Bone marrow transplantation. 19(7)
Summary: cancer centers. 10‐14 This report describes the 100-day treatment-related mortality (TRM) of the first 1000 consecutive patients receiving high-dose myeloablative chemotherapy High-dose chemotherapy (HDC) with autologous peripheral blood p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa9f12aa6ca6f6e3258d4792884daf27
https://pubmed.ncbi.nlm.nih.gov/9156243
https://pubmed.ncbi.nlm.nih.gov/9156243
Autor:
Mohan, Meera G.1,2 (AUTHOR), S., Adarsh1,2 (AUTHOR) adarsh_lce@yahoo.co.in
Publikováno v:
Theoretical & Applied Climatology. Nov2023, Vol. 154 Issue 3/4, p999-1011. 13p.